-
1
-
-
33845881411
-
Mechanisms linking obesity to insulin resistance and type 2 diabetes
-
doi:10.1038/nature05482
-
Kahn SE, Hull RL & Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006 444 840-846. (doi:10.1038/nature05482)
-
(2006)
Nature
, vol.444
, pp. 840-846
-
-
Kahn, S.E.1
Hull, R.L.2
Utzschneider, K.M.3
-
2
-
-
20444435873
-
FGF-21 as a novel metabolic regulator
-
doi:10.1172/JCI23606
-
Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR & Shanafelt AB. FGF-21 as a novel metabolic regulator. Journal of Clinical Investigation 2005 115 1627-1635. (doi:10.1172/JCI23606)
-
(2005)
Journal of Clinical Investigation
, vol.115
, pp. 1627-1635
-
-
Kharitonenkov, A.1
Shiyanova, T.L.2
Koester, A.3
Ford, A.M.4
Micanovic, R.5
Galbreath, E.J.6
Sandusky, G.E.7
Hammond, L.J.8
Moyers, J.S.9
Owens, R.A.10
Gromada, J.11
Brozinick, J.T.12
Hawkins, E.D.13
Wroblewski, V.J.14
Li, D.S.15
Mehrbod, F.16
Jaskunas, S.R.17
Shanafelt, A.B.18
-
3
-
-
70350322694
-
Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis
-
doi:10.1210/en.2009-0532
-
Badman MK, Koester A, Flier JS, Kharitonenkov A & Maratos-Flier E. Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology 2009 150 4931-4940. (doi:10.1210/en.2009-0532)
-
(2009)
Endocrinology
, vol.150
, pp. 4931-4940
-
-
Badman, M.K.1
Koester, A.2
Flier, J.S.3
Kharitonenkov, A.4
Maratos-Flier, E.5
-
4
-
-
33750587755
-
Fibroblast growth factor-21 improves pancreatic-cells function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathway
-
doi:10.2337/db05-1435
-
Wente W, Efanov AM, Brenner M, Kharitonenkov A, Köster A, Sandusky GE, Sewing S, Treinies I, Zitzer H & Gromada J. Fibroblast growth factor-21 improves pancreatic-cells function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathway. Diabetes 2006 55 2470-2478. (doi:10.2337/db05-1435)
-
(2006)
Diabetes
, vol.55
, pp. 2470-2478
-
-
Wente, W.1
Efanov, A.M.2
Brenner, M.3
Kharitonenkov, A.4
Köster, A.5
Sandusky, G.E.6
Sewing, S.7
Treinies, I.8
Zitzer, H.9
Gromada, J.10
-
5
-
-
34249711964
-
Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states
-
doi:10.1016/j.cmet.2007.05.002
-
Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS & Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metabolism 2007 5 426-437. (doi:10.1016/j.cmet.2007.05.002)
-
(2007)
Cell Metabolism
, vol.5
, pp. 426-437
-
-
Badman, M.K.1
Pissios, P.2
Kennedy, A.R.3
Koukos, G.4
Flier, J.S.5
Maratos-Flier, E.6
-
6
-
-
34249686631
-
Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21
-
doi:10.1016/j.cmet.2007.05.003
-
Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, Elmquist JK, Gerard RD, Burgess SC, Hammer RE, Mangelsdorf DJ & Kliewer SA. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metabolism 2007 5 415-425. (doi:10.1016/j.cmet.2007.05.003)
-
(2007)
Cell Metabolism
, vol.5
, pp. 415-425
-
-
Inagaki, T.1
Dutchak, P.2
Zhao, G.3
Ding, X.4
Gautron, L.5
Parameswara, V.6
Li, Y.7
Goetz, R.8
Mohammadi, M.9
Esser, V.10
Elmquist, J.K.11
Gerard, R.D.12
Burgess, S.C.13
Hammer, R.E.14
Mangelsdorf, D.J.15
Kliewer, S.A.16
-
7
-
-
34247565954
-
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
-
doi:10.1128/MCB.02249-06
-
Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, Xu C, Neubert TA, Zhang F, Linhardt RJ, Yu X, White KE, Inagaki T, Kliewer SA, Yamamoto M, Kurosu H, Ogawa Y, Kuro-o M, Lanske B, Razzaque MS & Mohammadi M. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Molecular and Cellular Biology 2007 27 3417-3428. (doi:10.1128/MCB.02249-06)
-
(2007)
Molecular and Cellular Biology
, vol.27
, pp. 3417-3428
-
-
Goetz, R.1
Beenken, A.2
Ibrahimi, O.A.3
Kalinina, J.4
Olsen, S.K.5
Eliseenkova, A.V.6
Xu, C.7
Neubert, T.A.8
Zhang, F.9
Linhardt, R.J.10
Yu, X.11
White, K.E.12
Inagaki, T.13
Kliewer, S.A.14
Yamamoto, M.15
Kurosu, H.16
Ogawa, Y.17
Kuro-o, M.18
Lanske, B.19
Razzaque, M.S.20
Mohammadi, M.21
more..
-
8
-
-
67649823642
-
FGF21 induces PGC-1a and regulates carbohydrate metabolism during the adaptive starvation response
-
doi:10.1073/pnas.0904187106
-
Potthoff MJ, Inagaki T, Satapati S, Ding X, He T, Goetz R, Mohammadi M, Finck BN, Mangelsdorf DJ, Kliewer SA &Burgess SC. FGF21 induces PGC-1a and regulates carbohydrate metabolism during the adaptive starvation response. PNAS 2009 106 10853-10858. (doi:10.1073/pnas.0904187106)
-
(2009)
PNAS
, vol.106
, pp. 10853-10858
-
-
Potthoff, M.J.1
Inagaki, T.2
Satapati, S.3
Ding, X.4
He, T.5
Goetz, R.6
Mohammadi, M.7
Finck, B.N.8
Mangelsdorf, D.J.9
Kliewer, S.A.10
Burgess, S.C.11
-
9
-
-
33846418834
-
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
-
doi:10.1210/en.2006-1168
-
Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, Hansen BC, Shanafelt AB & Etgen GJ. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 2007 148 774-781. (doi:10.1210/en.2006-1168)
-
(2007)
Endocrinology
, vol.148
, pp. 774-781
-
-
Kharitonenkov, A.1
Wroblewski, V.J.2
Koester, A.3
Chen, Y.F.4
Clutinger, C.K.5
Tigno, X.T.6
Hansen, B.C.7
Shanafelt, A.B.8
Etgen, G.J.9
-
10
-
-
57349098220
-
Fibroblast growth factor 21 corrects obesity in mice
-
doi:10.1210/en.2008-0816
-
Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, Moller DE & Kharitonenkov A. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 2008 149 6018-6027. (doi:10.1210/en.2008-0816)
-
(2008)
Endocrinology
, vol.149
, pp. 6018-6027
-
-
Coskun, T.1
Bina, H.A.2
Schneider, M.A.3
Dunbar, J.D.4
Hu, C.C.5
Chen, Y.6
Moller, D.E.7
Kharitonenkov, A.8
-
11
-
-
62149139387
-
Different roles of N- And C-termini in the functional activity of FGF21
-
doi:10.1002/jcp.21675
-
Micanovic R, Raches DW, Dunbar JD, Driver DA, Bina HA, Dickinson CD & Kharitonenkov A. Different roles of N- and C-termini in the functional activity of FGF21. Journal of Cellular Physiology 2009 219 227-234. (doi:10.1002/jcp. 21675)
-
(2009)
Journal of Cellular Physiology
, vol.219
, pp. 227-234
-
-
Micanovic, R.1
Raches, D.W.2
Dunbar, J.D.3
Driver, D.A.4
Bina, H.A.5
Dickinson, C.D.6
Kharitonenkov, A.7
-
12
-
-
0034697846
-
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
-
DOI 10.1016/S0167-4781(00)00067-1, PII S0167478100000671
-
Nishimura T, Nakatake Y, Konishi M & Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochimica et Biophysica Acta 2000 1492 203-206. (Pubitemid 30349198)
-
(2000)
Biochimica et Biophysica Acta - Gene Structure and Expression
, vol.1492
, Issue.1
, pp. 203-206
-
-
Nishimura, T.1
Nakatake, Y.2
Konishi, M.3
Itoh, N.4
-
13
-
-
73249138414
-
Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia
-
doi:10.2337/db09-0713
-
Hojman P, Pedersen M, Nielsen AR, Krogh-Madsen R, Yfanti C, Akerstrom T, Nielsen S & Pedersen BK. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes 2009 58 2797-2801. (doi:10.2337/db09-0713)
-
(2009)
Diabetes
, vol.58
, pp. 2797-2801
-
-
Hojman, P.1
Pedersen, M.2
Nielsen, A.R.3
Krogh-Madsen, R.4
Yfanti, C.5
Akerstrom, T.6
Nielsen, S.7
Pedersen, B.K.8
-
14
-
-
47949111205
-
Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states
-
doi:10.1124/mol.108.044826
-
Muise ES, Azzolina B, Kuo DW, El-Sherbeini M, Tan Y, Yuan X,Mu J, Thompson JR, Berger JP & Wong KK. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Molecular Pharmacology 2008 74 403-412. (doi:10.1124/mol.108. 044826)
-
(2008)
Molecular Pharmacology
, vol.74
, pp. 403-412
-
-
Muise, E.S.1
Azzolina, B.2
Kuo, D.W.3
El-Sherbeini, M.4
Tan, Y.5
Yuan, X.6
Mu, J.7
Thompson, J.R.8
Berger, J.P.9
Wong, K.K.10
-
15
-
-
48349127924
-
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man
-
doi:10.1016/j.cmet.2008.06.014
-
Gälman C, Lundåsen T, Kharitonenkov A, Bina HA, Eriksson M, Hafstrøm I, Dahlin M, Amark P, Angelin B & Rudling M. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. Cell Metabolism 2008 8 169-174. (doi:10.1016/j.cmet.2008.06. 014)
-
(2008)
Cell Metabolism
, vol.8
, pp. 169-174
-
-
Gälman, C.1
Lundåsen, T.2
Kharitonenkov, A.3
Bina, H.A.4
Eriksson, M.5
Hafstrøm, I.6
Dahlin, M.7
Amark, P.8
Angelin, B.9
Rudling, M.10
-
16
-
-
77955474305
-
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease
-
doi:10.1053/j.gastro.2010.04.054
-
Dushay J, Chui PC, Gopalakrishnan GS, Varela-Rey M, Crawley M, Fisher FM, Badman MK, Martinez-Chantar ML & Maratos-Flier E. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 2010 139 456-463. (doi:10.1053/j.gastro.2010.04.054)
-
(2010)
Gastroenterology
, vol.139
, pp. 456-463
-
-
Dushay, J.1
Chui, P.C.2
Gopalakrishnan, G.S.3
Varela-Rey, M.4
Crawley, M.5
Fisher, F.M.6
Badman, M.K.7
Martinez-Chantar, M.L.8
Maratos-Flier, E.9
-
17
-
-
78049297991
-
Obesity is a fibroblast growth factor 21 (FGF21)-resistant state
-
doi:10.2337/db10-0193
-
Fisher FM, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, Flier JS & Maratos-Flier E. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 2010 59 2781-2789. (doi:10.2337/db10-0193)
-
(2010)
Diabetes
, vol.59
, pp. 2781-2789
-
-
Fisher, F.M.1
Chui, P.C.2
Antonellis, P.J.3
Bina, H.A.4
Kharitonenkov, A.5
Flier, J.S.6
Maratos-Flier, E.7
-
18
-
-
48349146527
-
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
-
doi:10.2337/db07-1476
-
Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RL, Chow WS, Tso AW, Lam KS & Xu A. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008 57 1246-1253. (doi:10.2337/db07-1476)
-
(2008)
Diabetes
, vol.57
, pp. 1246-1253
-
-
Zhang, X.1
Yeung, D.C.2
Karpisek, M.3
Stejskal, D.4
Zhou, Z.G.5
Liu, F.6
Wong, R.L.7
Chow, W.S.8
Tso, A.W.9
Lam, K.S.10
Xu, A.11
-
19
-
-
39449127028
-
Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes mellitus
-
doi:10.1055/s-2007-985148
-
Chen WW, Li L, Yang GY, Li K, Qi XY, Zhu W, Tang Y, Liu H &Boden G. Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes 2008 116 65-68. (doi:10.1055/s-2007-985148)
-
(2008)
Experimental and Clinical Endocrinology & Diabetes
, vol.116
, pp. 65-68
-
-
Chen, W.W.1
Li, L.2
Yang, G.Y.3
Li, K.4
Qi, X.Y.5
Zhu, W.6
Tang, Y.7
Liu, H.8
Boden, G.9
-
20
-
-
77956276954
-
Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels
-
doi:10.1530/EJE-10-0454
-
Cuevas-Ramos D, Meda-Valdes P, Gómez P, Meza-Arana CE, Cruz-Bautista I, Rellano-Campos O, Navarrete L & Guilar-Salinas CA. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels. European Journal of Endocrinology 2010 163 469-477. (doi:10.1530/EJE-10-0454)
-
(2010)
European Journal of Endocrinology
, vol.163
, pp. 469-477
-
-
Cuevas-Ramos, D.1
Meda-Valdes, P.2
Gómez, P.3
Meza-Arana, C.E.4
Cruz-Bautista, I.5
Rellano-Campos, O.6
Navarrete, L.7
Guilar-Salinas, C.A.8
-
21
-
-
77957359658
-
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
-
doi:10.1016/j.jhep.2010.05.018
-
Li H, Fang Q, Gao F, Fan J, Zhou J,Wang X, Zhang H, Pan X, Bao Y, Xiang K, Xu A & Jia W. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. Journal of Hepatology 2010 53 934-940. (doi:10.1016/j.jhep.2010. 05.018)
-
(2010)
Journal of Hepatology
, vol.53
, pp. 934-940
-
-
Li, H.1
Fang, Q.2
Gao, F.3
Fan, J.4
Zhou, J.5
Wang, X.6
Zhang, H.7
Pan, X.8
Bao, Y.9
Xiang, K.10
Xu, A.11
Jia, W.12
-
22
-
-
0037339051
-
Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birth weight
-
doi:10.1210/jc.2002-021550
-
Hermann TS, Rask-Madsen C, Ihlemann N, Dominguez H, Jensen CB, Storgaard H, Vaag AA, Kober L & Torp-Pedersen C. Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birth weight. Journal of Clinical Endocrinology and Metabolism 2003 88 1252-1257. (doi:10.1210/jc.2002-021550)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, pp. 1252-1257
-
-
Hermann, T.S.1
Rask-Madsen, C.2
Ihlemann, N.3
Dominguez, H.4
Jensen, C.B.5
Storgaard, H.6
Vaag, A.A.7
Kober, L.8
Torp-Pedersen, C.9
-
23
-
-
53749088978
-
Mitochondrial function in skeletal muscle is normal and unrelated to insulin action in young men born with low birth weight
-
doi:10.1210/jc.2008-0630
-
Brøns C, Jensen CB, Storgaard H, Alibegovic A, Jacobsen S, Nilsson E, Astrup A, Quistorff B & Vaag A. Mitochondrial function in skeletal muscle is normal and unrelated to insulin action in young men born with low birth weight. Journal of Clinical Endocrinology and Metabolism 2008 93 3885-3892. (doi:10.1210/jc.2008-0630)
-
(2008)
Journal of Clinical Endocrinology and Metabolism
, vol.93
, pp. 3885-3892
-
-
Brøns, C.1
Jensen, C.B.2
Storgaard, H.3
Alibegovic, A.4
Jacobsen, S.5
Nilsson, E.6
Astrup, A.7
Quistorff, B.8
Vaag, A.9
-
24
-
-
16844380699
-
Low birth weight is associated with specific changes in muscle insulin signaling protein expression
-
doi:10.1007/s00125-005-1669-7
-
Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S &Vaag AA. Low birth weight is associated with specific changes in muscle insulin signaling protein expression. Diabetologia 2005 48 547-552. (doi:10.1007/s00125-005-1669- 7)
-
(2005)
Diabetologia
, vol.48
, pp. 547-552
-
-
Ozanne, S.E.1
Jensen, C.B.2
Tingey, K.J.3
Storgaard, H.4
Madsbad, S.5
Vaag, A.A.6
-
25
-
-
33750902947
-
Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight - Potential link to increased risk of diabetes?
-
doi:10.1007/s00125-006-0466-2
-
Ozanne SE, Jensen CB, Tingey KJ, Martin-Gronert MS, Grunnet L, Brons C, Storgaard H & Vaag AA. Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight - potential link to increased risk of diabetes? Diabetologia 2006 49 2993-2999. (doi:10.1007/s00125-006-0466-2)
-
(2006)
Diabetologia
, vol.49
, pp. 2993-2999
-
-
Ozanne, S.E.1
Jensen, C.B.2
Tingey, K.J.3
Martin-Gronert, M.S.4
Grunnet, L.5
Brons, C.6
Storgaard, H.7
Vaag, A.A.8
-
26
-
-
77954523386
-
Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weightdependent manner
-
doi:10.1210/jc.2009-2413
-
Brøns C, Jacobsen S, Nilsson E, Rönn T, Jensen CB, Storgaard H, Poulsen P, Groop L, Ling C, Astrup A & Vaag A. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weightdependent manner. Journal of Clinical Endocrinology and Metabolism 2010 95 3048-3056. (doi:10.1210/jc.2009-2413)
-
(2010)
Journal of Clinical Endocrinology and Metabolism
, vol.95
, pp. 3048-3056
-
-
Brøns, C.1
Jacobsen, S.2
Nilsson, E.3
Rönn, T.4
Jensen, C.B.5
Storgaard, H.6
Poulsen, P.7
Groop, L.8
Ling, C.9
Astrup, A.10
Vaag, A.11
-
27
-
-
65749091022
-
Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men
-
doi:10.1113/jphysiol.2009.169078
-
Brøns C, Jensen CB, Storgaard H, Hiscock NJ, White A, Appel JS, Jacobsen S, Nilsson E, Larsen CM, Astrup A, Quistorff B & Vaag A. Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. Journal of Physiology 2009 587 2387-2397. (doi:10.1113/jphysiol.2009. 169078)
-
(2009)
Journal of Physiology
, vol.587
, pp. 2387-2397
-
-
Brøns, C.1
Jensen, C.B.2
Storgaard, H.3
Hiscock, N.J.4
White, A.5
Appel, J.S.6
Jacobsen, S.7
Nilsson, E.8
Larsen, C.M.9
Astrup, A.10
Quistorff, B.11
Vaag, A.12
-
28
-
-
83455243036
-
Effects of high-fat overfeeding on mitochondrial function, glucose and fat metabolism, and adipokine levels in low-birth-weight subjects
-
doi:10.1152/ajpendo.00095.2011
-
Brøns C, Jacobsen S, Hiscock N, White A, Nilsson E, Dunger D, Astrup A, Quistorff B & Vaag A. Effects of high-fat overfeeding on mitochondrial function, glucose and fat metabolism, and adipokine levels in low-birth-weight subjects. American Journal of Physiology. Endocrinology and Metabolism 2011 302 E43-E51. (doi:10.1152/ajpendo.00095.2011)
-
(2011)
American Journal of Physiology. Endocrinology and Metabolism
, vol.302
-
-
Brøns, C.1
Jacobsen, S.2
Hiscock, N.3
White, A.4
Nilsson, E.5
Dunger, D.6
Astrup, A.7
Quistorff, B.8
Vaag, A.9
-
29
-
-
0025043679
-
Prediction of 24-h energy expenditure and its components from physical characteristics and body composition in normal-weight humans
-
Astrup A, Thorbek G, Lind J & Isaksson B. Prediction of 24-h energy expenditure and its components from physical characteristics and body composition in normal-weight humans. American Journal of Clinical Nutrition 1990 52 777-783.
-
(1990)
American Journal of Clinical Nutrition
, vol.52
, pp. 777-783
-
-
Astrup, A.1
Thorbek, G.2
Lind, J.3
Isaksson, B.4
-
30
-
-
0028819524
-
Glucose processing during the intravenous glucose tolerance test
-
doi:10.1007/BF00400638
-
Vaag A, Alford F, Henriksen FL, Christopher M & Beck-Nielsen H. Glucose processing during the intravenous glucose tolerance test. Diabetologia 1995 38 326-336. (doi:10.1007/BF00400638)
-
(1995)
Diabetologia
, vol.38
, pp. 326-336
-
-
Vaag, A.1
Alford, F.2
Henriksen, F.L.3
Christopher, M.4
Beck-Nielsen, H.5
-
31
-
-
0028802645
-
Loss of hepatic autoregulation after carbohydrate overfeeding in normal man
-
doi:10.1172/JCI118243
-
Clore JN, Helm ST & Blackard WG. Loss of hepatic autoregulation after carbohydrate overfeeding in normal man. Journal of Clinical Investigation 1995 96 1967-1972. (doi:10.1172/JCI118243)
-
(1995)
Journal of Clinical Investigation
, vol.96
, pp. 1967-1972
-
-
Clore, J.N.1
Helm, S.T.2
Blackard, W.G.3
-
32
-
-
33747075400
-
The effects of shortterm overfeeding on insulin action in lean and reducedobese individuals
-
doi:10.1016/j.metabol.2006.05.003
-
Cornier MA, Bergman BC & Bessesen DH. The effects of shortterm overfeeding on insulin action in lean and reducedobese individuals. Metabolism 2006 55 1207-1214. (doi:10.1016/j.metabol.2006.05.003)
-
(2006)
Metabolism
, vol.55
, pp. 1207-1214
-
-
Cornier, M.A.1
Bergman, B.C.2
Bessesen, D.H.3
-
33
-
-
43549110007
-
FGF21 attenuates lipolysis in human adipocytes - A possible link to improved insulin sensitivity
-
doi:10.1016/j.febslet.2008.04.038
-
Arner P, Pettersson A, Mitchell PJ, Dunbar JD, Kharitonenkov A &Rydén M. FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity. FEBS Letters 2008 582 1725-1730. (doi:10.1016/j.febslet.2008.04.038)
-
(2008)
FEBS Letters
, vol.582
, pp. 1725-1730
-
-
Arner, P.1
Pettersson, A.2
Mitchell, P.J.3
Dunbar, J.D.4
Kharitonenkov, A.5
Rydén, M.6
-
34
-
-
70349472910
-
Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice
-
doi:10.1016/j.febslet.2009.09.012
-
Li X, Ge H,Weiszmann J, Hecht R, Li YS, Véniant MM, Xu J,Wu X, Lindberg R & Li Y. Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice. FEBS Letters 2009 583 3230-3234. (doi:10.1016/j.febslet.2009.09.012)
-
(2009)
FEBS Letters
, vol.583
, pp. 3230-3234
-
-
Li, X.1
Ge, H.2
Weiszmann, J.3
Hecht, R.4
Li, Y.S.5
Véniant, M.M.6
Xu, J.7
Wu, X.8
Lindberg, R.9
Li, Y.10
-
35
-
-
79956113302
-
Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans
-
doi:10.1373/clinchem.2010.155184
-
Yu H, Xia F, Lam KS, Wang Y, Bao Y, Zhang J, Gu Y, Zhou P, Lu J, Jia W & Xu A. Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans. Clinical Chemistry 2011 57 691-700. (doi:10.1373/clinchem.2010.155184)
-
(2011)
Clinical Chemistry
, vol.57
, pp. 691-700
-
-
Yu, H.1
Xia, F.2
Lam, K.S.3
Wang, Y.4
Bao, Y.5
Zhang, J.6
Gu, Y.7
Zhou, P.8
Lu, J.9
Jia, W.10
Xu, A.11
-
36
-
-
80052519903
-
Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers
-
doi:10.1111/j.1365-2265.2011.04084.x
-
Andersen B, Beck-Nielsen H & Højlund K. Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers. Clinical Endocrinology 2011 75 514-519. (doi:10.1111/j.1365-2265.2011.04084.x)
-
(2011)
Clinical Endocrinology
, vol.75
, pp. 514-519
-
-
Andersen, B.1
Beck-Nielsen, H.2
Højlund, K.3
-
37
-
-
79954525448
-
Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese
-
doi:10.1371/journal.pone.0018398
-
Lin Z, Zhou Z, Liu Y, Gong Q, Yan X, Xiao J,Wang X, Lin S, FengW & Li X. Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese. PLoS ONE 2011 6 e18398. (doi:10.1371/journal.pone.0018398)
-
(2011)
PLoS ONE
, vol.6
-
-
Lin, Z.1
Zhou, Z.2
Liu, Y.3
Gong, Q.4
Yan, X.5
Xiao, J.6
Wang, X.7
Lin, S.8
Feng, W.9
Li, X.10
-
38
-
-
79952120254
-
Direct effects of FGF21 on glucose uptake in human skeletal muscle: Implications for type 2 diabetes and obesity
-
doi:10.1002/dmrr.1177
-
Mashili FL, Austin RL, Deshmukh AS, Fritz T, Caidahl K, Bergdahl K, Zierath JR, Chibalin AV, Moller DE, Kharitonenkov A & Krook A. Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes/Metabolism Research and Reviews 2011 27 286-297. (doi:10.1002/dmrr.1177)
-
(2011)
Diabetes/Metabolism Research and Reviews
, vol.27
, pp. 286-297
-
-
Mashili, F.L.1
Austin, R.L.2
Deshmukh, A.S.3
Fritz, T.4
Caidahl, K.5
Bergdahl, K.6
Zierath, J.R.7
Chibalin, A.V.8
Moller, D.E.9
Kharitonenkov, A.10
Krook, A.11
-
39
-
-
77955434383
-
Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1a pathway
-
doi:10.1073/pnas.1006962107
-
Chau MDL, Gao J, Yang Q, Wu Z & Gromada J. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1a pathway. PNAS 2010 107 12553-12558. (doi:10.1073/pnas.1006962107)
-
(2010)
PNAS
, vol.107
, pp. 12553-12558
-
-
Chau, M.D.L.1
Gao, J.2
Yang, Q.3
Wu, Z.4
Gromada, J.5
|